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Although the maturation and export ofT cells from the thymus has been extensively studied,
the movement of cells in the opposite direction has been less well documented. In particular,
the question of whether T cells which have been activated by antigen in the periphery are
more likely to return to the thymus had been raised but not clearly answered. We examined
this issue by activating T cells present in the periphery with their cognate antigen, and assess-
mice(Thyl.2 ), which recog- ing migration to the thymus. TCR-transgenic cells from OT-I
/
H-2K, were transferred into nlse the ovalbumin peptide OVA257_264 in the context of b
otherwise unmanipulated Thyl.1
/ C57BL/6 mice. Recipient mice were injected i.v. with 5 ktg
peptide (SIINFEKL) approximately 24 hours later. The numbers of donor-derived (Thyl.2+)
cells in the thymus and peripheral lymphoid tissue were determined. The results clearly show
increased numbers of transgenic cells in the thymus 3 days after antigenic stimulation. How-
ever, since numbers of transgenic cells increased in the spleen and LN in about the same pro-
portion, the data do not support the notion that there is highly increased selective migration of
activated T cells to the thymus. Rather, they suggest that a sample of peripheral cells enters
the thymus each day, and that the mature immigrants detected in the thymus merely reflect the
contents of the peripheral T cell pool.
Keywords: Thymus, T lymphocytes, Homing, Recirculation, Transgenic
Abbreviations: CFSE, carboxy fluorescein (diacetate) succinimidyl ester; LN, lymph node; MLN,
mesenteric lymph node; OT-I mice, OVA257_264-specific TCR-transgenic mice; OVA257_264, ovalbumin
peptide
INTRODUCTION thymus migrate to the spleen and lymph nodes (LN),
especially early in life, and in the absence of a thymus
The thymus is the primary source of T cells for the these organs remain essentially devoid ofT cells. This
peripheral lymphoid organs. T cells produced in the pathway has been extensively quantitated in a number
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of species, and in young adult animals represents an
export rate of about 1% of thymocytes per day (Scol-
lay et al., 1980; Scollay and Shortman, 1985).
The reverse pathway, of mature T cells migrating
from the periphery back into the thymus is less often
considered, although several studies have shown that
this is not a major pathway in normal animals
(Dumont et al., 1984; Michie et al., 1988; Hirokawa
et al., 1989; Agus et al., 1991). Our own unpublished
data suggest that about 1% of the mature phenotype
cells in the thymus may be mature T cell immigrants
(Coward and Scollay, in preparation). Some studies
have suggested that this pathway might preferentially
be used by activated T cells. An early report indicated
that activated antigen-specific T cells migrated to the
thymus, and persisted there, whereas migration of
non-activated cells to the thymus was not detected
(Naparstek et al., 1982). Similarly, Fink et al. (1984)
demonstrated that peripheral T cells activated in vivo
provide a greater contribution to the thymic memory
CTL response than non-activated cells. In that study,
it was not possible to determine the proportion of thy-
mocytes which were donor derived. More recently, it
was shown that blasts (generated in parent F com-
binations) homed to the thymus, and represented
approximately 0.4% of mature T thymocytes,
although the rate of homing was greatly increased by
irradiation of hosts (Agus et al., 1991). Others have
shown that, compared to ’naive’ CD4+ T cells, there is
a preferential accumulation of antigen-experienced T
cells in the rat thymus (Bell et al., 1995; Westerman et
al., 1996). As is the case for ’normal’ peripheral T
cells (Hirokawa et al., 1989), accumulation of acti-
vated cells within the thymus is largely restricted to
the medulla (Pabst and Binns, 1989; Agus et al.,
1991; Westermann et al., 1996).
One shortcoming of the above studies is that
thymic immigration of in vivo-activated clonal T cell
populations has not been analysed. As part of a longer
study on migration of mature cells into the thymus,
we have addressed this question in a model where
TCR transgenic T cells present only in the periphery
could be stimulated with their cognate peptide, and
their migration to the thymus assessed. OT-I mice
(Hogquist et al., 1994) carry a transgene for a MHC
class I-restricted TCR with Vc2 and V135 variable
regions. The TCR recognises the ovalbumin peptide
OVA257_264 presented by H-2Kb, the MHC haplotype
of C57BL/6 mice. In these mice, the great majority of
peripheral T cells are CD8/CD4-, and express the
transgenic TCR (Koniaris et al., 1997). These cells
are readily activated in vivo upon administration of
the OVA peptide (Koniaris et al., 1997).
The data described in this paper clearly demon-
strate increased numbers of transgenic cell in the thy-
mus after peripheral antigenic stimulation, but since
cell numbers are also increased in the periphery, the
results do not support the concept that activated cells
show selective migration to the thymus.
RESULTS
Phenotype of Donor Cell Inoculum
Phenotyping of pooled donor spleen and LN cells
prior to transfer indicated that CD8+ cells were far
more prevalent than CD4
/ cells (CD4:CD8 ratio of
approximately 1:9), and that the majority (97%) of
CD8
/ cells expressed Vt2 chains in their TCR, and
were therefore peptide specific (Figure 1A&B).
Quantitation ofDonor-Derived Cells in Peripheral
Lymphoid Organs
Recipient animals were anaesthefised, and perfused
with PBS and FCS. Spleen and Mesenteric LN
(MLN) cell suspensions were prepared, and stained to
quantitate and phenotype donor-derived cells. In con-
trol mice which had been injected with donor cells
followed by PBS instead of peptide three days previ-
ously, a population of donor-derived cells could be
clearly seen, which comprised approximately 2% of
total splenocytes, or 10 to 21% of CD8+ splenocytes
(Figure 1C; Table I). Similarly, in the LN,
donor-derived cells represented 3 to 5% of total LN
cells, or 9 to 18% of CD8
/ cells (Figure 1E; Table I).
Three days post-peptide injection, donor-derived cells
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FIGURE Phenotype of donor OT-I transgenic cells (A&B). Analysis for expression of donor marker (Thy1.2) and presence of transgenic
TCR (V2) among gated CD8+ cells in recipient spleen and MLN 3 days after injection of PBS or peptide (C-F). (A) CD4 versus CD8
expression by donor lymphocytes prior to injection. (B)V2 expression by donor CD8 lymphocytes prior to injection. Representative of one
donor cell inoculum, pooled from 13 OT-I donor mice. Plots from spleen ofPBS (C) or peptide-injected (D) mice, and fromMLN ofPBS (E)
or peptide-injected (F) mice. The proportion of total CD8+ lymphocytes that were donor-derived (Thyl.2+) is indicated. Representative of
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approximately 66% of CD8+ splenocytes. Three days
post-peptide, donor-derived cells represented 27% of
total LN cells, and approximately 50% of CD8+ LN
cells (Figure 1D&F; Table I). Thus, there was a large
increase in donor-derived Ag-specific cells in periph-
eral lymphoid tissue three days after peptide injection.
By day six after peptide, the proportion of total lym-
phocytes and CD8+ lymphocytes which were
donor-derived was similar to the control PBS-injected
group (Table I).
When total cell numbers were considered, there
was a 2 to 3-fold expansion in the number of spleno-
cytes 3 days after peptide injection. This difference
was not apparent 6 days after peptide, nor was it seen
when LN cell numbers were compared. When abso-
lute donor (Thyl.2/) cell numbers were compared,
there was a 15 to 20-fold expansion in spleens, and a
6 to 8-fold expansion in MLN 3 days after peptide
injection, leading to an approximate 15 to 20-fold
increase in the number of donor-derived cells in the
total peripheral pool (based on the assumption that the
total cell pool in all LNs is small relative to cell num-
bers in the enlarged spleen). Six days post-peptide
there were negligible increases in absolute Thyl.2
/
cell numbers (Table I).
TABLE Percentage and absolute numbers of splenocytes and LN cells which were donor-derived
Group % oftotal cells % ofCD8 cells Total cell# (106) Thyl.2 cell# (106)b
Experiment 1
PBS spleen 3d 2.2 +/- 0.1 (2.2, 2.3, 2.1)
Peptide spleen 3d 11.6 +/- (12.7, 11.6, 10.6)
10 +/- (11, 9, 10) 77 +/- 8 (84, 68, 78) 1.7 +/- 0.1 (1.8, 1.6, 1.6)
64 +/- 0.2 (64, 65, 64) 228 +/- 61 (184, 298, 202) 26 +/- 7.6 (23, 35, 21)
Fold increase 5 x 7 x 3 x 15 x
Control LN 3d 2.9 +/- 0.2 (2.8, 3.1, 2.8) 9 +/- 0.6 (9, 10, 9) 17 +/- 4.9 (20, 11, 19) 0.5 +/- 0.2 (0.6, 0.3, 0.5)
Peptide LN 3d 25 +/- 3 (28, 22, 25) 48 +/- 4.6 (53, 44, 47) 15 +/- 5.9 (22, 13, 11) 4 +/- 2 (6.3, 2.9, 2.9)
Fold increase 9 x 5 x 0.9 x 8 x
Experiment 2
Control spleen 3d 1.3, 1.8 22, 20 114, 106 1.5, 1.9
Peptide spleen 3d 17.4 +/- 0.7 (17.6, 16.6, 67 +/- 3 (70, 64, 68) 195 +/- 44 (152, 192, 240) 34 +/- 8.4 (26.8, 31.9, 43.2)
18)
Fold increase 11 x 3 x 2 x 20 x
Control LN 3d 4, 5.7 17, 20 18, 19 0.7, 1.1
Peptide LN 3d 29 +/- 3.1 (28, 26, 32) 53 +/- 3 (53, 50, 56) 19 +/- 3 (18, 16, 22) 5.5 +/- 1.4 (5.1, 4.3, 7)
Fold increase 6 x 3 x x 6 x
Control spleen 6d 1.2 +/- 0.3 (1.2, 0.9, 1.4) 12 +/- 0.6 (12, 11, 12) 97 +/- 25 (72, 98, 122) 1.2 +/- 0.5 (0.9, 0.9, 1.7)
Peptide spleen 6d 1.6 +/- 0.8 (1.5, 2.5, 0.9) 13 +/- 3 (14, 16, 10) 121 +/- 15 (110, 138, 116) 2.1 +/- 1.3 (1.7, 3.5, 1)
Fold increase x x x 2 x
Control LN 6d 2.9 +/- 0.3 (3.2, 2.6, 2.8) 11 +/- 0.6 (11, 10, 11) 13 +/- 3 (15, 15, 10) 0.4 +/- 0.1 (0.5, 0.4, 0.3)
Peptide LN 6d 2.3 +/- 1.0 (1.7, 3.4, 1.7) 8 +/- 3.6 (5, 12, 7) 20 +/- 6 (15, 27, 19) 0.5 +/- 0.3 (0.3, 0.9, 0.3)
Fold increase 0.8 x 0.7 x 1.5 x x
a. Mean +/- one standard deviation (individual values).
b. Value derived from % total lymphocytes and cell number.
c. Student’s t-test, control versus peptide-injected.
d. Values from spleen andMLN of control mice not infused with Thyl.2 cells (background with cThyl.2 Ab) were 0.05 1%.
e. Values from spleen andMLN of control mice not infused with Thyl.2 cells (background with cThy1.2 Ab) were 0.03 0.2%.THYMIC IMMIGRATION OF ACTIVATED PERIPHERAL LYMPHOCYTES 127
Quantitation of Donor-Derived Cells
in the Thymus
Following anesthesia, animals were perfused with
PBS in order to flush out any circulating,
donor-derived cells from the thymus. In control,
PBS-injected mice (i.e. donor cell-injected but no
peptide), 1:2 to 41 per 105 thymocytes were
donor-derived 3 days post-PBS injection, whilst 417
to 1043 per 105 thymocytes were donor-derived
(Thyl.:2+) in the peptide-injected group (Table II).
These differences translated into :25 to 35-fold
increases in the proportion of donor-derived cells in
the peptide-injected group at the earlier time-point
(Figure :2C&D; Table II). By day 6 after peptide, the
difference in proportions of donor-derived cells was
reduced to 3.5-fold (Figure :2E&F; Table II). In terms
of total cell numbers, the thymuses of pep-
tide-injected mice had slightly fewer cells than those
of PBS-injected mice (Table II). However, compared
to PBS-injected mice, the absolute number of
donor-derived (Thyl.2/) cells detected in the thymus
was increased 16 to 20-fold 3 days after peptide
administration (Table II). This difference was reduced
to 3-fold at the latter time-point (Table II).
Proportions of Transgene-Expressing (Vt2+)
Donor-Derived CD8+ Cells
In order to ensure that donor-derived cells were
indeed potentially antigen responsive, we assessed the
proportion of donor CD8
/ cells which were Vet2+.
Apart from slightly lower values in the thymus at day
6 after peptide administration, essentially all (approx-
imately 95%) CD8
/ cells expressed the transgenic
Vct2 chain in their TCR (Table III), and were there-
fore antigen-specific.
TABLE II Proportional and absolute number of thymocytes which were donor-deriveda, three and six days after peptide stimulation
Group Immigrants/lO5 cellsb’c Total cell# (106) Thyl.2 cell# (104)d
Experiment 1
PBS 12 +/- 4 (16, 13, 8) 169 +/- 37.2 (204, 130, 174) 2 +/- (3, 2, 1)
Peptide 417 +/- 139 (576, 358, 318) 95 +/- 13.3 (104, 80, 102) 40 +/- 17 (60, 29, 32)
Fold increase 35 x 0.6 x 20 x
Experiment 2
PBS 3d 30, 52 176, 214 5, 11
Peptide 3d 1043 +/- 283 (1159, 720, 1249) 119 +/- 38 (84, 114, 160) 127 +/- 64 (97, 82, ,200)
Fold increase 25 x 0.6 x 16 x
PBS 6d 35 +/- 4 (30, 38, 37) 133 +/- 36 (108, 174, 118) 5 +/- 2 (3, 7, 4)
Peptide 6d 121 +/- 13 (117, 135, 110) 112 +/- 14 (128, 104, 104) 13.5 +/- 2 (15, 14, 11)
Fold increase 3.5 x 0.8 x 3 x
a. Mean +/- one standard deviation (individual values).
b. Background values (no ctThyl.2 Ab) were 0.1 per 105 cells.
c. Values for control mice stained with ctThyl.2 but not infused with Thyl.2 cells were 4 17 immigrants/105 cells.
d. Value derived from % immigrants and total cell number.
TABLE III Percentage of donor-derived (Thyl.2+) CD8+ cells which were Vc2
Mouse (n) Thymus Spleen MLN
Control 3d (2) 92.3 +/- 0.1 96.2 +/- 2.0 95.8 +/- 0.1
Peptide 3d (3) 97.9 +/- 0.2 94.9 +/- 0.2 95.4 +/- 0.6
Control 6d (3) 78.6 +/- 9.2 95.7 +/- 0.4 96.4 +/- 0.6
Peptide 6d (3) 97.2 +/- 1.8 95 +/- 1.2 96.4 +/- 0.7
a. Mean +/- one standard deviation.128 CHARLES L. HARDY et al.
DISCUSSION
Although thymic maturation and rates of thymic
export of mature T cells have been extensively stud-
ied (Scollay et al., 1980; Scollay and Shortman,
1985), the reverse pathway, of immigration of mature
T cells into the thymus, has been less well analyzed.
The current study aimed to determine whether T cells
activated in the periphery show increased selective
migration to the thymus. By activating peripheral T
cells with specific antigen in vivo we could avoid
some of the pitfalls of previous studies, in which acti-
vated cells were adoptively transferred (Naparstek et
al., 1982; Fink et al., 1984; Agus et al., 1991; Bell et
al., 1995; Westermann et al., 1996). While the cells
involved had been transferred from congenic donors,
and had suffered the rigors of being prepared as cell
suspensions, they were not manipulated in any other
way. This model is therefore relatively physiological,
as there was no organ transplantation or recipient
manipulation (apart from the i.v. injection), and pro-
vides a situation in which there is a population of T
cells present in the periphery but absent from the thy-
mus unless there has been immigration. Our data con-
firm experiments in other systems (Dumont et al.,
1984; Michie et al., 1988; Hirokawa et al., 1989;
Agus et al., 1991) which show that migration back to
the thymus in normal, unstimulated animals is very
low, and also confirm our own experiments using car-
boxy fluorescein (diacetate) succinimidyl ester
(CFSE)-labeled cells from normal, non-transgenic
donors which show the same thing (Coward and Scol-
lay, in preparation). Those CFSE experiments also
showed long-term survival and apparently normal
migration of transferred spleen and LN cells in this
experimental set up. Other studies show similar
long-term survival and/or tissue-specific migration of
fluorescein isothiocyanate-labeled cells (Butcher et
al., 1980; Chin and Cahill, 1984; Abernethy et al.,
1990; Witherden et al., 1990). For the experiments in
this paper, the transferred T cells were allowed
approximately 24 hours for ’recovery’ before antigen
stimulation in order to minimize any effects of the
earlier ex vivo manipulation.
It was clear that the transferred transgenic T cells
were stimulated to proliferate in vivo with the specific
peptide, as evidenced by the loss of CFSE staining
intensity (not shown) and the large increase in cell
numbers. This was true three days after stimulation,
although by 6 days, most of the donor cells had appar-
ently disappeared, presumably due to antigen induced
apoptosis, as shown in similar systems by several
investigators (Webb et al., 1990; Kyburz et al., 1993;
Moskophidis et al., 1993; Koniaris et al., 1997).
Three days after antigen administration, there were
significant changes in the sizes of the lymphoid
organs. The cellularity of the thymus was reduced,
presumably due to the well characterised stress effects
often associated with experimental manipulation,
including delivery of antigen. The reduced thymic
cellularity may have been due to deletion of cortical
thymocytes, possibly mediated by cortico-steroids or
TNF produced by peripherally activated T cells (Mar-
tin and Bevan, 1997). In contrast, the cellularity of the
peripheral organs was increased, due to expansion of
the transgenic T cells and cytokine-induced
"bystander" proliferation (Tough et al., 1996; Ehl et
al., 1997). For this reason we have focussed this dis-
cussion on absolute T cell numbers, as it is difficult to
interpret the relevance of changes in proportion in the
face of varying organ sizes.
There Was clearly an increase in the number of
cells which migrated into the thymus following anti-
gen-specific T cell activation in the periphery, con-
firming the findings of earlier studies (Naparstek et
al., 1982; Fink et al., 1984; Agus et al., 1991; Bell et
al., 1995; Westermann et al., 1996). This increase
amounted to about 16 to 20-fold 3 days after injection
with peptide. However, at this same time point there
had also been an increase in the number of cells in the
periphery, by about 15 to 20-fold in the spleen and 6
to 8-fold in the MLN. In these animals with enlarged
spleens, this must represent an increase in the total
peripheral pool only slightly less than the 15 to
20-fold value seen in the spleen. Thus, the increase in
the thymus (16 to 20-fold) was very close to that seen
in the periphery (approximately 15 to 20-fold). There-
fore, the results do not support the notion that there is
preferential migration of activated peripheral T cells
back to the thymus. Rather they support the idea that
there may be a steady level of migration of activatedTHYMIC IMMIGRATION OF ACTIVATED PERIPHERAL LYMPHOCYTES 129
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FIGURE 2 Identification of intrathymic, donor-derived (Thy1.2+) transgene positive (Va2+) cells in control and peptide-injected mice. Plots
were generated by forward versus side light scatter gating on whole thymocytes. Background staining (no Thyl.2 Ab) 3 days after injection
of PBS (A) or peptide (B). Plots from mice 3 days after injection of PBS (C) or peptide (D), or 6 days after injection of PBS (E) or peptide
(F). Percentages of donor-derived cells are indicated. Representative of 3-6 mice
peripheral cells to the thymus which is proportional to
their numbers in the periphery. While it is clear that
our data do not prove such a model, they are consist-
ent with it, but not with a preferential migration
model.
There is one additional point which should be
made. We cannot exclude the possibility that the
increased numbers of transgene-positive donor cells
in the thymus result from proliferation inside this
organ, rather than increased migration. Our data do
not allow us to distinguish between these alternatives.
Previous investigations of immigration of mature T
cells to the thymus were limited by the fact that acti-
vated cells were defined and purified on the basis of
cell-surface marker expression (Bell et al., 1995;
Westermann et al., 1996), or involved adoptive trans-
fer of previously activated cells (Fink et al., 1984;
Agus et al., 1991). Additionally, measurement of
immigrating cells has frequently relied upon rela-
tively non-quantitative radioactive, immunohisto-
chemical or in vitro cell culture techniques (Naparstek
et al., 1982; Fink et al., 1984; Westermann et al.,
1996). By transferring large numbers of clonal T cell
populations, administering specific peptide several
days later, and quantitating thymic immigrants by
flow cytometry we have been able to circumvent
some of these shortcomings. Our results are in broad
agreement with the previous studies, showing an
enhanced accumulation of activated cells within the
thymus, but for the first time allowing a comparison130 CHARLES L. HARDY et al.
of changes in the pool from which the activated cells
have come.
The functional significance of peripheral T cells in
the thymus, especially previously activated T cells, is
unknown. It has been suggested that, since the thymic
medulla contains both epithelial and bone mar-
row-derived cells which express both MHC and
co-stimulatory molecules (Picker and Siegelman,
1999), it is a potential site for immune reactions
(Michie et al., 1988), although there is no clear evi-
dence to support such a case. However, it is possible
that the presence of activated cells in the thymus
might play a role in intrathymic selection and matura-
tion events, as suggested by several investigators
(Naparstek et al., 1982; Michie et al., 1988; Agus et
al., 1991). Such a mechanism would presumably
require delivery to, and recognition of, peripher-
ally-derived peptides within the medulla, which may
selectively alter production of thymic emmigrants.
The possibility that such peptide/self-antigen plays an
important role in medullary proliferation or emigra-
tion remains to be demonstrated (see Scollay and
Godfrey, 1995 for discussion).
MATERIALS AND METHODS
Mice
Normal female C57BL/6 Ka-Thyl.1 mice 8 wk of age
were bred and housed under clean conditions in the
Centenary Institute animal facility. Homozygous OT-I
V2/V5 TCR-transgenic mice, specific for OVA257_
264 (243-2 line, back-crossed to Thyl.2
/ C57BL/6
mice) (Hogquist et al., 1994) were the generous gift
of Dr. Bill Heath (Walter and Eliza Hall Institute of
Medical Research, Melbourne Australia). Donor OT-I
mice were used at 2-4 months of age.
Monoclonal Antibodies and Flow Cytometry
Approximately 3 106 cells per sample were stained
in 96 well U-bottomed tissue culture plates. Bioti-
nylated Vt2 (clone B20.1) was obtained from Dr. Bill
Heath. Thy1.2-FITC, CD4-APC, CD8-PE,
TCR-PE, B220-PE and CD69-biotin (Pharmin-
gen, San Diego, CA); streptavidin-Tricolour and
CD4-Tricolour (Caltag Laboratories, Burlingame,
CA), and streptavidin-Texas Red (Molecular Probes
Inc., Eugene, OR) were purchased. Cells were labeled
with appropriately diluted biotinylated primary anti-
body for 15-20 min, washed twice, and incubated
with streptavidin-Tricolour and fluorescent-conju-
gated monoclonal antibodies for 15-20 min. Antibod-
ies were diluted in 3% FCS in balanced salt solution
(BSS). All staining volumes were 40 1, and all steps
were performed at 4C. Flow cytometric data was
acquired on a FACScan or FACStar (Becton Dickin-
son and Co., San Jose, CA).
Cell Transfer and Peptide Injection
Spleen and LN were collected from one transgenic
donor mouse per recipient, cell suspensions prepared,
and red blood cells lysed for 5 min in ammonium
chloride lysis solution. The cell suspension was
pooled and washed in 3% FCS/BSS 3-4 times (400g
for 7 minutes at 4C), and viable cells counted in a
hemocytometer. The cells (approximately 108 from
each donor) were resuspended in PBS and injected
into the tail vein of recipient mice in a volume of 200
tl. Injection of donor OT-I cells was performed on 2
consecutive days, such that each recipient received a
total of approximately 2 108 cells. Recipient mice
were injected intravenously (i.v.) with 5 tg peptide
(SIINFEKL) in 200 tl PBS approximately 24 hours
after the second transfer of OT-I cells.
Harvesting of Tissues
Animals were anaesthetised with avertin (2%
2,2,2-Tribromoethanol and 2% tert-Amyl-alcohol
[Aldrich Chemical Company, WI]), injected with
100 U of heparin, and perfused via the left ventricle
with 25 ml of warmed (30-37C) PBS containing 3%
FCS and 5 U/ml heparin. This procedure removed
most blood from the lung and thymus, leaving them a
’white’ color, thus minimizing contamination of thy-
mocytes with donor-derived cells present in the circu-THYMIC IMMIGRATION OF ACTIVATED PERIPHERAL LYMPHOCYTES 131
lation. Other experiments (Coward and Scollay, in
preparation) have demonstrated that blood contami-
nation does not contribute significantly to thymocyte
preparations made in this way. The thymus was har-
vested prior to spleen and MLN. Organs were passed
gently through a stainless steel sieve with the end of
syringe plunger, and washed twice in 3% FCS/PBS
prior to counting. Care was taken at all stages to avoid
contamination of thymus samples with cells from
spleen or MLN.
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